Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
The opportunity was published in detail in every financial statement. Of course it was available to the public. All it required was experience, analysis and the ability through maturation to see the opportunity, as many have. Best to focus on share price, remediation and non-petulant focus on the positive opportunity at hand, again.
Very common in merchant banking.
Any merchant banker investing $3 million in BIEL would demand at least 35% of the equity. That would be 19 Billion of the Whelan's 25 Billion shares. And they would probably do the deal.
It is not mentioned that the usery loans yielding discounted shares and 8% interest, also paid only in shares, leaves the lender with continuing very high risk shares in a company with a share price in the toilet after 15 years. Should be remembered before trashing.
Do you mean expiration of her SEC Barment resulting from her conviction?
Dec 2019 - it was a 1 year bar from any involvement in penny stocks.
Aaaaahhhh, so blissful, la la la la
There were a number of email reachouts to chat about this precise opportunity subject, in positive and constructive ways, with no response . . . .
Remember this precise moment.
The beautiful thing is it is now out of all our hands and under the watchful eyes of others . . . . .
Thank you PT. Numerous people in our group have reached out to industry and career contacts all over the world to source hundreds of leads to determine what and how this debacle has evolved, yet the share price remains in the toilet. We all know the tiresome results of revealing 20 or more items that either make no sense or lead one to make dark assumptions.
No one in their right mind could assume we have revealed everything uncovered or the mother lode, could they? It all points in one direction and to one solution.
Thanks again.
Remember this precise moment my friend.
Remember this precise moment my friend.
It is mid-afternoon in Sydney, NSW.
It has been learned, by one of our contacts, a pharma Sydney Sider, that mundipharma has issued an ultimatum to the current CBO, CEO. Get your business affairs fully in order by the end of the month, including issuance of a renewed CE Mark, to allow export of ActiPatch to Australia, or provide for the return our up-front license agreement payment of $350,000USD or face litigation on the grounds of lack of specific performance under our agreement.
If anyone doubts the seriousness of this, call mundi in Sydney.
Ok, Q3 for dramatic sales results from all that is transpiring. Based on all the news from BIEL on McKesson PLUS B.Braun sales activities, plus mundipharma's 350 sales reps and their sales in Australia and numerous other PacRim countries, plus sales by the turned on 200 sales reps in Russia and Ukraine, plus the news that the VA has had ActiPatch available since last November - 9 million vets. Incredible!
BIEL could still be a $2 Billion company in Q3 of this year, instead of the longer 2019/2020 period suggested! I accept the suggestion that Q2 results will only reflect the start of these incredible events. Wow!
Still can't wait! Breathless with anticipation, after FDA all-body clearance July 1. Markets must still react wildly any minute now, because that's what markets and market makers do, instantly, every time, without fail. Amazing stuff!
Read 188368 and 188372.
Seems far less work and time involved in just agreeing and not voicing the truthful opinions of others forming dissenting opinions acquired after many months of hard work and investigation. You're right luke, this one's on the shareholders to bring home. I am confident as to where this is going and there is no need for repetition.
That's interesting news. Never heard of anyone considering a stockholder vote. I assume other entities, who know exactly what the situation is, will provide solutions.
Ok, Q3. Based on all the news from BIEL on McKesson PLUS B.Braun sales activities, plus mundipharma's 350 sales reps and their sales in Australia and numerous other PacRim countries, plus sales by the turned on 200 sales reps in Russia and Ukraine, plus the news that the VA has had ActiPatch available since last November - 9 million vets. Incredible!
BIEL could still be a $2 Billion company in Q3 of this year, instead of the longer 2019/2020 period suggested! I accept the suggestion that Q2 results will only reflect the start of these incredible events. Wow!
Still can't wait! Breathless with anticipation, after FDA all-body clearance July 1. Markets must still react wildly any minute now, because that's what markets and market makers do, instantly, every time, without fail. Amazing stuff!
Well bobby, tunes change all the time don't they?
Amazing, guaranteed expectations of sales ongoing right now by B.Braun, 200 sales reps in Russia and Ukraine, 350 mundipharma sales reps flogging ActiPatch all day, every day. Plus ActPatch apparently available to 9 million vets through the VA since November 2018.
Even though it all seems too good to be true, the speculation must be true. Right?
How can we possibly wait for the amazing Q2 positive sales results? On pins and needles, that's how. The silly CBO, CEO issues will surely take care of themselves, because amazing sales and profits and a $2 Billion company matter most, right?
Wow! Wow, Wow! Combining your post about McKesson PLUS my post 188347 about B.Braun, mundipharma's 350 sales reps, sales and the turned on 200 sales reps in Russia and Ukraine, maybe BIEL could be a $2 Billion company this year instead of the longer 2019/2020 longer period you suggest? Q2 results will have to reflect these events.
Can't wait! Breathless with anticipation after FDA all-boys clearance July 1. Markets must react any minute now, because that's what markets and market makers do, instantly, every time, without fail.
Looking forward to amazing Q2 sales results of a couple of million dollars, maybe more, reflecting the mundipharma 350 sales reps results and incredible online sales in Australia for the past few months under Distributor mundi....can't wait.
How have they all got around need for CE Mark to export to Australia? I don't know, but I salute their dexterity in getting around those Regs. Add in your news about 200 sales reps in Russia and Ukraine selling ActiPatch hard and we won't be able to cope with the amazing sales results....550 sales reps in total, all pushing ActiPatch and Recovery Rx hard? I'm breathless in anticipation.
When one combines the wonderful additional news about B. Braun and mundipharma, especially with the FDA all-body clearance of RecoveryRx at the 1st of July, the BIEL share price should be running hard any minute, because that's what stockmarkets do, they reflect wonderful news immediately, in anticipation of guaranteed results! It's July 10, any minute now. BAMMM
So, because I remained always factual, constructive and sometimes critical, which was admired, and my opinion of the current BIEL CBO, CEO changed through learning new information, previously unknown, that is a good enough reason to now mistrust.... I think I get it.
Sort of like, if another person's opinions are the same as mine, that's okay and I'm trusted. But, opinions become different, because one learns new, truthful, factual information, trust is not there anymore.
I guess that means I'm okay on never having agreed with many things the CBO, CEO did and therefor never trusting him completely to be an experienced, knowledgeable, successful, FDA, pharma business executive for his stockholders. Blind trust is rarely good. Trust is earned.
I think that's a good thing because I learned a lot of new information that conclusively proves a large group of experienced business people were and remain correct in their opinions that he has screwed up just about everything he has touched, for years, except staying in 5 positions for 30 months too long. CBO, CEO, President, CFO and Chairman of a one Director BoD of a public company. Yup, he stayed on too long, very well, even after declaring his wish to retire in March.
Best move would have been to have retired to Chairman in Feb 2017 right after FDA clearance of the foot and knee. BIEL would be selling ActiPatch through Bayer/Dr. Scholl's, KT Tape and CVS in the USA. Add on NHS, the EU countries and mundipharma
because the CE Mark sure as hell would have been reviewed before expiring and we would have a stock trading at about a dime, instead of in the toilet.
By the way, this is not grandstanding by looking at something 20/20 in hindsight. Many people observed accurately the health and aging issues developing as early as 2014 and advised the CBO, CEO he was in trouble. The majority of the BoD resigned together just before the FDA foot and knee clearances, because the now erratic CBO, CEO defiantly refused to agree to preparing his succession plan, and they were confident of the mess that would continue. They were right, it has and the proof of all this is abundant!
Since then, Bayer, KT Tape, CVS, CE Mark, deferred sales, mundi wants its money back, the the share price remains in the toilet 10 days after RecoveryRx received its FDA all body clearance. I trust the facts and the irrefutable proof. This is not pleasant and it is very difficult for many to grasp and accept, after believing in and supporting for so long.
But it was ActiPatch we were all supporting and I still am. I was 2 years late in changing my opinion and only started after I felt I was missing something and looked for it. I was late compared to some. Facts and truth are what they are.
Noooo, it's actually totally accurate and truthful and provable and several people have the proof . . . . :)
Nothing lost srin. The Whelans are either selling shares issued on conversion of notes....or someone else is selling shares issued against an IBEX convertible note that was sold to that person; with the shares then sold by a cooperating broker. Note is converted, broker sells shares, transfer agent is instructed to deliver shares to selling broker for fulfillment. That's the Whelan way. How the funds are received and used will be fascinating. A circuitous journey can raise red flags...
.
It will be interesting to see the details, and they will be seen......
Read 188127 very, very carefully. I know, for a fact that the man was putting thousands of miles on his vehicle representing BIEL to the equestrian world - I have a photo of it.
Why take the word of anyone? It ain't good news time, we are in the middle of a cluster and the cluster is in the toilet. The solutions are sooo obvious. More importantly, it should never have happened!
2 days ago . . .
"Here is Andy's actual quote (grammatical error and all):
Keith is being interviewed by UpTick Radio in the mornings which will answer most of your questions."
From the current CBO, CEO, who expressed to several people in March that he wanted to retire. . . . . . No one could ever write this chit.
As said, if the CBO, CEO is not an inept, over the hill, bungler, the stock price should have risen just with speculation of real deals and sales, that's how markets react and discount great news early. If he is an inept, over the hill, bungler, then the price will stay in the toilet and he needs to retire. Simple. A stock running because of a regulatory clearance, which BIEL products have deserved for years, is not indicative of competent management. Imagine what the company could easily do, if both components were present....
Managing a company successfully for its stockholders and employees is not difficult, if management has the aptitude. Without it or a good dose of me, me, me, Founder's Syndrome with aging and failing faculty issues, can make success, always, just out of reach or maybe next month or just around the next corner. A rise of .0002 on the announcement of an FDA clearance on RecoveryRX? Outrageous. is there still anyone not believing that it may just be time?
Two good questions CM. They call it mfg in US because it is packaged here. On the CE Mark, any stockholder can call the original agent who processed the CE Mark application for BIEL. They will find out that the current CBO, CEO did not pay the agent, so the agent gave up in frustration, after much patience, and stopped communicating. Oooops, the CE Mark expired.
None of any of this is complicated. Don't even ask how pi$$ed I was to hear the answer from one of our stockholders who went after the truth!
Don't pay one of your service providers and you get dropped by them in disgust, then you get to disappoint EU distributors who have worked to sell your products, in good faith, then you get to report $536K in devices sitting in a back corridor as "Deferred Sales" on your financial statements? Who, in their right mind, defers sales. Then, after someone revealed the truth of what happened, the criticism started....oh no, you're wrong, impossible, you're nuts, over and over and over. Really? Now its 'new regulations in 2020'. Really? The whole world is shipping into the EU, including the UK, but not our beloved BIEL, nope, we had to defer sales because of new regulations. The bills were't paid! Imagine the EU distributors and how pi$$ed they are. All that work and zero, no shipments, no sales, no reorders, no customers helped with their pain. Imagine the $$$ wasted and potential lost.
Have someone in Sydney order and then call re shipment. They will be advised that the first order from the USA is being delayed in customs, the old stand=by in Australia. . . .
Someone is right here, but its not about 'who' is right, it's only about 'what' is right. The good thing is that the amazing sales growth emanating from the following 4 reasons, part of the best 12 reasons to invest in BIEL list will be reflected in the Q2 sales figures. . . . won't they?
3. Company has “3 Substantive Orders” Ready to Ship after Clearing Regulatory issues. ($531K in "Deferred Sales" according to the financial statements. Sitting in a corridor at BIEL because the current CBO, CEO allowed the CE Mark to expire -didn't tell the stockholders and when it was first reported here, was rejected as false. Ooops, seems it's now true. . . . you will recall when we saw the photo of the 7 pallets sitting at BIEL's offices, we smelled something was wrong, then determined it had to be a shipping issue, then decided it had to be a regulatory issue and checked into the CE Mark. Sure enough, it had expired and still it was highly critically denied for months after. Yup, we were the fools, imagine talking about a CE Mark expiring! If you've paid for one, you know it has an expiry date and your agent often advises you so, as the date approaches, hoping to retain you as a client. Make sense?)
4. Veterans Administration Now Makes Actipatch Available to 9 Million Veterans. as of 11/14/2018 (How come VA sales didn't show up in the Q1 sales results? 9 million is a lot of veterans and since it became available last November, there must be a couple of million $$ missing from the Q1 reported sales)
5. MundiPharma has Rolled Out Actipatch in Australia and New Zealand. (yup, that was last year too, so where were the sales in Q1? Oh, okay, guess they will show up in Q2.)
7. B Braun Is Using RecoveryRX in the U.K., Germany and Australia for Surgeries. First 3 of 64 Countries. (Unfortunately, B. Braun has not been in the picture for some time. According to the current CBO, CEO. He told a couple of people, should have told the stockholders, wouldn't you think? Call B. Braun and dig for the answers, like we did.)
Imagine all the opportunities . . . and sales . . . and profits . . . and share price.
Don't be so sure....this text is part of your first link
Quote
"Limited Stock*
Our stock is running a little low. We will process your order, however we cannot confirm that we will be able to supply this product.
In the event we are unable to supply, we will contact you to organise an immediate refund.
Call 1300 463 342 if you would like to confirm available quantities."
Best info we have is mundipharma has demanded return of its up-front distributor fee and BIEL has not made a shipment, other than samples, into Australia. Call mundi and ask them, they were very open with one of our contacts in Australia, they found out the CE Mark had expired and were very unhappy.
Incidentally, we feel with the right funding and management changes needed (retirement of the current CBO, CEO, as he stated to several people he wished to do in March) we may be able to save a number of disastrous situations created by the CBO, CEO. This is just another item on the management report card . . . Share price, sales, negotiating style, management style, open to new ideas, tolerant and patience, public speaking, fiscal responsibility, transparency, character, integrity, believable, humility, task completion, realistic forecasting, shareholder relations, leadership, trustworthy.
You call it the quiet storm before the massive hurricane of BIEL's success. Funny, I used to call it a pending Tsunami, in my blind support of the CBO, CEO, before we went to work and found out the details of his non-negotiator and non-management styles. Stupid me, I drank the kool-aid because I believed in ActiPatch, as I still very much do. Hell, I'm wearing one right now!
But, a great start-up guy, which Whelan was in the very early days, is one thing and usually makes for a crappy senior management executive. No question, he should've brought in FDA legal counsel at day one, but, nope, he could do it himself! And his most frequent phrase after imploding the Bayer/Dr. Scholl's. KT Tape and CVS deals was, X them, I'll do it myself.
You see, doc, if you can get your head around the fact that Whelan actually believes he is the smartest guy in the room, every time, and truly believes he is the only one who knows what he is doing, AND believes all stockholders are stupid and should shut up and not question his decisions, then you will have the picture settings correctly adjusted. How do I know? You would be truly amazed how we know. Place just a little faith in the facts that we have done good work and know what we are doing.
Yes, of course, there are 3 sides to every story, his, hers and the truth. When a dissenting opinion has as its underlying goals, success for the company and its employees and stockholders, it becomes very easy to sort out the truths, especially when one major truth is found in the report card for management, the share price. FDA clearance for RecoveryRx for all body parts? Are you kidding me? BIEL should be at 3 cents, even if the current CBO, CEO had produced an average management performance! Stockholders we've spoken with and professionals in the pharma, retail, corporate space just cannot believe he imploded the deals by saying no, because he couldn't get them to agree to his incredulous negotiating style. If you don't agree, he walks out. Truly amazing! BIEL should be selling millions of dollars every month, instead of Q1 sales at $141K.....another subject on the management report card . . . . Imagine.
It is never about blame when assessing the performance of a CEO of a publicly traded company, as it is he or she who is entrusted with carrying out the Fiduciary Duty responsibilities set down by law as to how stockholder funds and investments are managed.
The staff at BIEL are first class, altho shaking their heads most of the time. They know exactly what the situation is and how to best resolve the issues, make no mistake about that. The staff do not stand behind the CEO and do not support his decisions. They are victims too and there have been many defections over the years, of employees who went on to better and investors either who got fed up and took their hits or many who just said no thanks.
You only referred to 1/2 of McDonald's. Don't forget more than double that for the Whelan IBEX shares tucked away in convertible Promissory Notes. And don't forget to add the interest machine grinding away at 8%. Short term stockholder loans to help a start-up company are one thing, okay, I get that concept.
But 25 Billion shares worth, when it is the CBO, CEO's daughter, who has an office at BIEL? And they all testified, father and daughter, under oath, verbally and by affidavit, in response to the SEC charges that, no, no, no, she was never involved in the company, nope, she's her own person, you've got that wrong Mr. SEC, wink, wink, nudge, nudge, say no more..... What??? What idiot would believe that? Clue....the SEC could not have like that veracity.
Of course she has never been involved in the management of the company, she's a CPA! And the Whelans learned about the Prom Note Revolver scheme from a couple of slick New York guys who skinned them for a few million many years ago and then did it themselves! Another case of Whelan learning how to do it himself and inserting himself and his daughter into the scheme, to benefit themselves. Helping a tiny company survive a rough patch, waiting for the FDA, $50K, $100K, short-term was one thing, but 25 Billion shares? That's another!
So scoreoneortwo, you can probably figure on 45 to 50 billion shares with the Whelans having about 55% of them....unless some entity rules that Billions of those shares were gained by malfeasance or self-dealing and rules those transactions invalid. In which case, arms length stockholders like you and me and hundreds of other good people who invested in ActiPatch will vote to reduce the Whelans to a position of justly rewarding them for their good work in the start-up phases. But such rulings take time this company may not have and are very costly. It's one thing when stockholders feel they have been hard done by and want justice, quite another when they are asked to write checks to pay lawyers for that justice.
I, like so many, invested in ActiPatch, a magical, safe, efficacious pain management miracle device. But I also try to run my business with my head, not my heart. Read post 187984 about my wake up process and I was later than some.
As said, if Whelan is not an inept, over the hill, bungler, the stock price should have risen ten-fold with FDA clearance for RecoveryRx a few days ago and speculation of real deals and sales, as markets react and discount great news early. FDA clearance for the whole body? It should have run to a couple of cents. It has not! Why? The CBO, CEO and saying no to 3 huge players in the retail sector!
If he is an inept, over the hill, bungler, then the price will stay in the toilet and he needs to retire. Simple. A stock running because of a regulatory clearance, which BIEL products have deserved for years, is not indicative of competent management. Imagine what the company could easily do, if both components were present....
Managing a company successfully for its stockholders and employees is not difficult, if management has the aptitude, as a team, and an effective leader. Without it, and the realities of a good dose of me, me, me, Founder's Syndrome can make success, always, just out of reach or maybe next month or just around the next corner, as has been the case for years.
I won't apologize for lengthy posts, ever, because putting a company into the toilet can take one week or years, but always take longer and money to turnaround. Imagine saying no to Bayer/Dr. Scholl's, KR Tape and CVS and you have another glimpse at advancing age issues. Who does that? Always far better and safer to have a smaller piece of a bigger pie. You'll never starve and you rarely go broke! Have a great day.
I don't believe, for a second, anyone should ever have to eat their words, after voicing opinions, nor should anyone be made to feel they must slink away. If everyone agreed on everything , nothing would change. My only goal is to have my investment cared for with respect by a well managed company.
Thanks very much yankee, for seeing what I believe to be the truth. I recall your supportive posts of BIEL and Whelan over the years. Like you, I was highly supportive up until the two FDA OTC clearances for the foot and knee in Feb 2017.
My goals are just as simple as the truths I have posted.
Responsible, reliable and transparent good governance of BIEL by all Officers and Directors, free of self-dealing and malfeasance. How simple can it be? Create success for all shareholders.
In future, if an expanded BoD deems it appropriate for potential investors to be granted stock options, then open it up publicly to all, with reasonable minimum investment thresholds, so everyone might participate, even if it becomes a matter of pooling resources.
Reasonable investment, offering reasonable returns, without the absurd self-dealing Whelan and his daughter engineered and engaged in repeatedly for years, yielding them >20 BILLION shares, while he was CBO, CEO, CFO, President and Chairman of the Board. It will be interesting to see if every dollar went toward keeping BIEL afloat or if sticky fingers kept some along the way won't it?
You're totally on the money PT, it's only a matter of common sense. A number of people here have been approached by the turnaround crew asking if we would invest new funds and consider standing for appointment on an expanded BoD. I have been on a number of BoD's and, as I learned subsequently, 6 people were being considered, taking the BoD to 7 plus an Advisory Board and the responses were independent and unanimous. Yes to consideration, but only if the current CBO, CEO retires to Chair only of the expanded BoD, as proposed, with a strong non-interference obligation.
And I have not sold one share, why would I....I understand and believe in ActiPatch!
Call your dozens of contacts in the pharma and retail industries, as we did by much digging over a 5 month period. You will be amazed, as we were. As to proof, believe it or don't believe it, but ask yourself a simple question. Why would I risk negatively affecting BIEL by saying anything but the truth, the whole truth, etc., etc. Then check share price and think FDA, RecoveryRx, whole body clearance, no retail deals, toilet sales and share price.
Second, why the family would tolerate it. Ever tried to talk to an overbearing parent about stopping driving? Now add Founder's Syndrome, ego, stubbornness (Whelan's trade mark attribute) and his sadly mistaken belief for years that he was always the smartest person in every room.
Psssst. Drs. Staelin, Koneru and Rawe worked tirelessly on the RecoveryRx clearance.
Thank you PT. You know how much I hate revealing what we know to be the truth about our bumbling, incompetent CBO, CEO. It is factual that I defended Whelan through all his gaffes and mismanagement of the FDA processes for years and supported him in thousands of posts. Facts!
My eyes began to open POST-USA, FDA, OTC Clearances in Feb 2017 for the foot and knee, when there was no immediate follow-up announcing major deals with big retailers? What? I and several others quietly went to work. Failing health - multiple heart attacks, advancing aging issues, 2 of 3 Directors resign within a month of the FDA clearances, Dr. Richard Staelin of Duke University, who is a genius at FDA and ActiPatch, and Mary Whelan, CBO, CEOS' sister and great businesswoman. We looked at ourselves in amazement? How come?
November 2018, I went silent, too busy for BIEL and a mountain of DD was being very carefully assessed. It just didn't add up. Magical, safe, efficacious, non-drug pain device, FDA cleared, two years, no sales and silence? What was missing? One key component. What was it? The CBO, CEO, CFO, President, Chairman and Director of a one-person BoD. The health, aging, Founder's Syndrome, no retail deals, no sales were all adding up.
Only then did we call around to numerous industry parties supposed to be negotiating with BIEL. They all confirmed that Whelan had arrogantly imposed himself into discussions Keith Nalepka was having with Bayer/Dr. Scholl's, KT Tape and CVS and killed all those deals. He undermined the discussions by saying, No!"
What to do? iHUB followers now know what's up and how to turn BIEL around, particularly after Whelan expressed to numerous people in March his wish to retire. The erratic behavior since, lack of deals, toilet sales and share price are all evidence that stockholders are being disadvantaged. If not, share price would have exploded last week on the FDA clearance of RecoveryRx post-op for the whole body. Not the foot or knee, not the back or the shoulder, not for one gender and not the other.....the whole body! A week later, the share price remains in the toilet!
Who does this to himself, when he and his daughter and family own >half the company? More that 22 Billion shares in convertible notes, etc.? Someone who can't get out of his own way because of 3 issues. Founder's Syndrome, advancing aging issues and management aptitude. But a turnaround plan was designed that would raise new funds, make retail deals and immediately raise the share price out of the toilet.
The Whelan family members would already be ahead of where they are by many tens of millions, but the tyrannical CBO, CEO remains in charge mumbling, "They are all stupid idiots, I'll do it by myself." his current mantra, one he has muttered for years!
It takes courage and tough love to stop a parent from driving or a family patriarch from singlehandedly destroying his legacy and an entire family's financial opportunity. It's all been said and it's only about management incompetence, retail deals, sales and share price. Want to see 3 cents/share? Be part of creative change, not toilet status quo. More Regulatory and civil litigation or criminal investigations are not the answers, they take much time and money and are only effective after the doors close. The key is positive change and the only constant in life is change.
With all the blatant hype about B.Braun doing billions in annual sales, leader in surgical hardware and Braun having been on board for a couple of years, it's so simple, where are the sales? The incompetent BIEL CBO, CEO thought he could cut everyone out and allowed the CE Mark for exporting into the EU expire, believing he could ship direct to users one at a time.
No CE Mark also killed mundipharma in the western PacRim, no wonder they are demanding their up-front license fee be returned! If Braun were selling, it would mean more than the Q1 sales of BIEL ($141K) per WEEK! Imagine 13 weeks, Q1, $10,000 per week. Braun would be doing that each and every day, if it were involved at all! The toilet sales make Braun's involvement impossible!
This led to 7 pallets of patches for EU Distributors frozen at BIEL HQ for a year and $531K reported as "Deferred Sales" in Financial Statements. What? And the company is crying for market penetration and sales? Imagine the loss of those sales, at retail, disappointed users and furious Distributors? And no repeat orders?
Who does this to himself, when he and his daughter own >50% of BIEL stock? A guy with advancing serious health and aging issues, who actually believes he can do it all by himself. No wonder the share price remains in the toilet after FDA clearance of RecoveryRx for the WHOLE BODY less than 10 days ago. The stock should've run to 3 cents. How come it hasn't? Why so glum? The CBO, CEO. The market doesn't trust him to manage the company to where it should be. Especially while he and his daughter are SEC barred from activities relating to penny stocks.
You're absolutely right PT...makes zero sense.
Whelan fought to have Boots carry ActiPatch. Boots purchased, then marked the device up to retail pricing and everyone was happy, particularly UK users with chronic and acute pain.
When ActiPatch was added to the universal health insurance program, NHS, once again Whelan thought he could have it all and cut out retailers. He pulled the device from Boots OTC. Whelan actually believed Physicians would write the ActiPatch in the thousands daily from the get go. No clue that by being added to the NHS listing just means now you get to spend millions educating Physicians to write Rx's for your products. That's what bag- carrying Reps and hospital Reps do, they promote their wares, all day, every day in MD offices and hospitals.
Add up the retailers and retail suppliers Whelan has said "No" to.... Boots, Bayer/Dr. Scholl's, KT Tape, CVS. Who says "No" to millions daily, yes, daily in retail sales and profit building share price? Someone inept.
As said, if Whelan is not an inept, over the hill, bungler, the stock price should have risen ten-fold with FDA clearance for RecoveryRx a few days ago and speculation of real deals and sales, as markets react and discount great news early. It has not!
If he is an inept, over the hill, bungler, then the price will stay in the toilet and he needs to retire. Simple. A stock running because of a regulatory clearance, which BIEL products have deserved for years, is not indicative of competent management. Imagine what the company could easily do, if both components were present....
Managing a company successfully for its stockholders and employees is not difficult, if management has the aptitude, as a team, and an effective leader. Without it, and the realities of a good dose of me, me, me, Founder's Syndrome can make success, always, just out of reach or maybe next month or just around the next corner, as has been the case for years.
Who cares, share price remains in the toilet and Whelan and his daughter were charged by the SEC, then tried, convicted, sentenced, fined and barred from involvement in penny stocks. What a fiasco - a magic pain device, instead of drugs, all it needed was competent management. Instead, stockholders are victims of the personal foibles of a guy who can't get out of his own way, while he runs a great opportunity into the toilet, while negotiating with great companies like Dr. Scholl's, KT Tape and CVS! Absurd! And he and his daughter own more than half the company! Who does this to themselves?
Despite all the recent speculation of dramatic share price runs, it remains in the toilet. Disruptive technology magic device, in the toilet? Must be a reason that makes sense.
A great question for Dr. Sree Koneru at BIEL, call him, he will have that in his head.
Hmmmm
5X stronger than ActiPatch, yet the delivery specifications, signal MHz frequency and pulse rate - 1,000/second are the same as ActiPatch?
RecoveryRx specs are:
Carrier frequency 27.12MHz
Peak spatial power density73 microwatts/cm²
Pulse rate1000 pulses per second
Pulsed on duration100 micro seconds
Power sourceBattery
Antenna size12cm or 8cm
Treatment area100cm2 of 70cm2
Weight8 grams
Operation time720 hours (on/off capability) or 170 continuous hours
Perhaps the first part is the most accurate...perhaps what Whelan wants more than anything is validation... How much of the complexities of this guy is his own ego, of wanting to be a somebody. When you learn of his childhood, it makes a lot of sense.
All of which is to say, who cares? See last paragraph.
Tough childhood, in the military, along with millions of others, bookkeeper, very good startup guy, entrepreneur, fine work ethic. It's all no longer relevant. By whatever fate, this man is CBO, CEO, CFO, founder, President, Chairman and only Director of a public company (absurd in itself). His advancing health and aging issues have exacerbated earlier traits, as happens to most adults, to where Founder's Syndrome and stubbornness are blinding reality. BIEL is in the toilet financially.
As said, if Whelan is not an inept, over the hill, bungler, the stock price should have risen ten-fold with FDA clearance for RecoveryRx a few days ago and speculation of real deals and sales, as markets react and discount great news early. It has not!
If he is an inept, over the hill, bungler, then the price will stay in the toilet and he needs to retire. Simple. A stock running because of a regulatory clearance, which BIEL products have deserved for years, is not indicative of competent management. Imagine what the company could easily do, if both components were present....
Managing a company successfully for its stockholders and employees is not difficult, if management has the aptitude, as a team, and an effective leader. Without it, and the realities of a good dose of me, me, me, Founder's Syndrome can make success, always, just out of reach or maybe next month or just around the next corner, as has been the case for years.
Who cares, share price remains in the toilet and Whelan and his daughter were charged by the SEC, then tried, convicted, sentenced, fined and barred from involvement in penny stocks. What a fiasco - a magic pain device, instead of drugs, all it needed was competent management. Instead, stockholders are victims of the personal foibles of a guy who can't get out of his own way, while he runs a great opportunity into the toilet, while negotiating with great companies like Dr. Scholl's, KT Tape and CVS! Absurd! And he and his daughter own more than half the company! Who does this to themselves?
Really? If you check through past financial statements very carefully, the clues are found there.
We know of two liens currently in place against the IP of BIEL.
Kelly Whelan has one on behalf of IBEX. The Import & Export Bank has another as collateral on a loan that had an original principal amount of $500,000. All public information.
We know of two liens currently in place against the IP of BIEL.
Kelly Whelan has one on behalf of IBEX. The Import & Export Bank has another as collateral on a loan that had an original principal amount of $500,000. All public information.
Do not forget for one second, there are two additional points of scrutiny over what both Whelans do in terms of fiduciary duty and malfeasance with stockholder's investments.
One is the SEC, which no doubt is closely watching both Whelans. Remember Kelly Whelan testimony, under oath and by affidavit, that she was not involved in the management of BIEL, only IBEX. CBO, CEO Whelan testified to that as well. Hogwash! I think the other interested party may have been revealed too. Inconceivable they have not been alerted.
As said, if the CBO, CEO is not an inept, over the hill, bungler, the stock price should have risen ten-fold with FDA clearance for RecoveryRxa few days ago and speculation of real deals and sales, as markets react and discount great news early.
If he is an inept, over the hill, bungler, then the price will stay in the toilet and he needs to retire. Simple. A stock running because of a regulatory clearance, which BIEL products have deserved for years, is not indicative of competent management. Imagine what the company could easily do, if both components were present....
Managing a company successfully for its stockholders and employees is not difficult, if management has the aptitude. Without it, or a good dose of me, me, me, Founder's Syndrome can make success, always, just out of reach or maybe next month or just around the next corner, as has been the case for years.